Published in Endokrinologie on January 01, 1969
Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis (2001) 1.72
How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp Dermatol (2005) 1.51
Acute postnatal increase of extracellular antioxidant defence of neonates: the role of iron metabolism. Acta Paediatr (2001) 1.39
High prevalence of silent celiac disease in preschool children screened with IgA/IgG antiendomysium antibodies. J Pediatr Gastroenterol Nutr (1999) 1.30
Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol (2001) 1.29
Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus. Pediatr Res (1999) 1.12
Resiniferatoxin-type phorboid vanilloids display capsaicin-like selectivity at native vanilloid receptors on rat DRG neurons and at the cloned vanilloid receptor VR1. Br J Pharmacol (1999) 1.02
Chlorpropamide antidiuresis. Lancet (1969) 0.99
Specificity of trypsin and alpha-chymotrypsin towards neutral substrates. Acta Biochim Biophys Acad Sci Hung (1976) 0.93
Successful extraction of complicated cataract in a patient suffering from haemophilia B. Acta Ophthalmol (Copenh) (1965) 0.87
A non-pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptors. Br J Pharmacol (1999) 0.85
A high sensitive method for the measurement of ATPase activity. Anal Biochem (1977) 0.83
Acute phase proteins in patients with chronic periapical granuloma before and after surgical treatment. Oral Microbiol Immunol (1988) 0.83
Troponin C like protein of blood platelets. FEBS Lett (1977) 0.83
Evaluation of different methods for detecting circulating immune complexes. Studies in patients with lung cancer. J Immunol Methods (1981) 0.81
Combination of carbamazepine and chlorpropamide in the treatment of "hyporesponder" pituitary diabetes insipidus. J Clin Endocrinol Metab (1974) 0.81
Circulating immune complexes and phagocytic activity of polymorphonuclear cells in patients with glomerulopathies. Clin Nephrol (1979) 0.81
Measurement of Na+/K+-ATPase activity with an automated analyzer. Clin Chem (1997) 0.81
Hyperkalemic intermittent paralysis associated with spironolactone in a patient with cardiac cirrhosis. Am Heart J (1968) 0.80
Electrophysiological effects of intrapericardial infusion of endothelin-1. Pacing Clin Electrophysiol (1998) 0.80
Hyperkalemic changes during spironolactone therapy for cirrhosis and ascites, with special reference to hyperkalemic intermittent paralysis. J Am Geriatr Soc (1968) 0.80
Functional and structural properties of Na+/K(+)-ATPase enzyme in neonatal erythrocytes. Eur J Clin Invest (1998) 0.80
Effect of propranolol on heart rate variability in patients with end-stage renal disease: a double-blind, placebo-controlled, randomized crossover pilot trial. Clin Nephrol (2004) 0.79
1-desamino-8-D-arginine vasopressin (DDAVP) concentration test. Am J Med Sci (1978) 0.79
The effect of growth hormone on the plasma levels of T4, free-T4, T3, reverse T3 an TBG in hypopituitary patients. Acta Endocrinol (Copenh) (1981) 0.79
Enhanced accumulation of pericardial fluid adenosine and inosine in patients with coronary artery disease. Life Sci (1999) 0.79
Distinct features of recombinant rat vanilloid receptor-1 expressed in various expression systems. Cell Mol Life Sci (2003) 0.79
Biologic blood markers reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism. Acta Med Hung (1991) 0.79
Experimental glomerular lesions induced by chronic immune complex formation. I. Formation and elimination of the immune complex (relationship between the immune status and the glomerular changes). Int Urol Nephrol (1979) 0.79
The selective endothelin-A-receptor antagonist LU 135.252 inhibits the direct arrhythmogenic action of endothelin-1. J Cardiovasc Pharmacol (2000) 0.79
Arrhythmogenic action of endothelin-1. Cardiovasc Res (2000) 0.79
Studies directed towards efficient synthesis of oligo-5'-deoxy-5-C-(phosphonomethyl)deoxyribonucleosides. Nucleic Acids Symp Ser (1991) 0.78
Enchancement of polyuria by glibenclamide in diabetes insipidus. Lancet (1971) 0.78
Glucose-induced hyperkalemia in diabetic subjects. Arch Intern Med (1981) 0.78
Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP-1. Allergy (2002) 0.77
Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus. Pharmacology (1977) 0.77
Bosentan the mixed endothelin-A- and -B-receptor antagonist suppresses intrapericardial endothelin-1-induced ventricular arrhythmias. J Cardiovasc Pharmacol (2000) 0.77
[Gastric and duodenal intramural hematoma: report of two cases]. Orv Hetil (1998) 0.77
Vitamins and continuous ambulatory peritoneal dialysis (CAPD). Int Urol Nephrol (1985) 0.77
Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man. Endokrinologie (1975) 0.77
Arteriovenous shunt-circulation in lymphoedematous limbs. Acta Chir Hung (1986) 0.77
Convenient synthesis of dinucleotide methylphosphonates. Nucleic Acids Symp Ser (1991) 0.77
Hyperhomocysteinaemia and MTHFR C677T gene polymorphism in renal transplant recipients. Arch Dis Child (2001) 0.76
Investigation of the diuretic effect of glibenclamide in healthy subjects and in patients with pituitary and nephrogenic diabetes insipidus. Horm Metab Res (1974) 0.76
Change in antikaliuretic response to potassium-sparing diuretics in patients with cirrhotic ascites. J Am Geriatr Soc (1976) 0.76
Anti-glucagon antibodies in diabetes mellitus. Ann Immunol Hung (1973) 0.76
Decreased antidiuretic response in diabetes insipidus during prolonged treatment with carbamazepine presumably due to enzym-induction. Endokrinologie (1976) 0.76
Comparative study of alloimmune reactions induced by leukocyte and platelet transfusions in humans: characteristic changes of activation markers, gamma interferon, and FcR blocking antibody production. Hum Immunol (1988) 0.76
Endothelin-A-receptor antagonist LU 135.252 inhibits the formation of ventricular arrhythmias caused by intrapericardial infusion of endothelin-1. J Cardiovasc Pharmacol (2000) 0.76
Effect of ACTH-stimulated glucocorticoid hypersecretion on the serum concentrations of thyroxine-binding globulin, thyroxine, triiodothyronine, reverse triiodothyronine and on the TSH-response to TRH. Acta Med Acad Sci Hung (1979) 0.75
The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man. Int J Clin Pharmacol Biopharm (1976) 0.75
Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop. Horm Metab Res (1976) 0.75
Increase in plasma renin level and aldosterone excretion in response to bethanidine sulfate (Esbatal) in a patient with renovascular hypertension. Endokrinologie (1969) 0.75
Adrenocortical insufficiency in spite of high corticosteroid excretion in a patient with thyrotoxicosis. Endokrinologie (1968) 0.75
Relationship between the dose of chlorpropamide administered intravenously and the antidiuretic effect in diabetes insipidus. Pharmacology (1970) 0.75
Prolongation of duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) by ineffective doses of clofibrate in diabetes insipidus. Horm Metab Res (1975) 0.75
Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus. Acta Diabetol Lat (1975) 0.75
Glucose-induced hyperkalemia developing in the upright position in captopril-treated hypertensives. Res Commun Chem Pathol Pharmacol (1982) 0.75
Individual differences in the antidiuretic response induced by DDAVP in diabetes insipidus. Horm Metab Res (1976) 0.75
Glucose-induced hyperkalemia during captopril treatment. Arch Intern Med (1983) 0.75
Simultaneous occurrence of hyperkalemia due to aldosterone suppression and hyperfunctioning parathyroid adenoma. Endokrinologie (1982) 0.75
Use of furosemide for evaluation of the urinary concentrating mechanism in chronic pyelonephritis. J Am Geriatr Soc (1968) 0.75
Inhibition of the antidiuretic effect of 1-deamino-8d-arginine vasopressin (DDAVP) by glibenclamide in water-loaded healthy subjects. Endokrinologie (1975) 0.75
Paradoxical increase of peripheral glucose utilization in a patient with insulinoma treated with prednisolone. Endokrinologie (1966) 0.75
Dose-response relations in drug-induced inappropriate secretion of ADH: effects of clofibrate and carbamazepine. Int J Clin Pharmacol Biopharm (1975) 0.75
Drug-induced inhibition of the diuretic response to water loading in partial vasopressin responsive nephrogenic diabetes insipidus. Int J Clin Pharmacol (1974) 0.75
Use of a simple fluorometric 11-hydroxycorticosteroids assay in the assessment of spironolactone-metabolite level in plasma and urine. Endokrinologie (1974) 0.75
Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone. Int J Clin Pharmacol Ther Toxicol (1982) 0.75
Evidence for permanent enhancement of residual ADH induced by antidiuretic agents (chlorpropamide, carbamazepine, clofibrate) in patients with pituitary diabetes insipidus. Endokrinologie (1975) 0.75
Studies on the mechanism of "chlorpropamide antidiuresis" in diabetes insipidus. Endokrinologie (1970) 0.75
Free water excretion due to suppressed vasopressin and stimulated aldosterone during sodium restriction in hypoaldosteronemic renal failure. Endokrinologie (1982) 0.75
Aldosterone and cortisone requirement and metabolism in Addison's disease complicated by thyrotoxicosis. Endokrinologie (1967) 0.75
A role for the upright posture in the development of glucose-induced hyperkalemia; prevention by a mineralocorticoid. Horm Metab Res (1982) 0.75
Glucose-induced hyperkalemia in normaldosteronemic diabetes associated with hyperthyroidism. Endokrinologie (1981) 0.75
Interference of triameterene with cortisol determination in urine. Horm Metab Res (1974) 0.75
Extreme antidiuresis in response to chlorpropamide administered intravenously during angiotensin infusion in diabetes insipidus. Med Exp Int J Exp Med (1969) 0.75
Effect of body posture on the serum potassium response to glucose in healthy subjects, diabetics and hyperthyroid patients. Exp Clin Endocrinol (1984) 0.75
Reversal of glucose-induced hyperkalemia by sodium restriction in "normaldosteronemic" diabetes mellitus. Endokrinologie (1981) 0.75
Clinico-pharmacological investigations with chlorpropamide in diabetes insipidus associated with diabetes mellitus. Endokrinologie (1970) 0.75
Clinical value of the combinations of carbamazepine (tegretol), chlorpropamide (diabinese) and vasopressin in the treatment of pituitary diabetes insipidus. Endokrinologie (1973) 0.75
Effects of ethacrynic acid on specific renal functions without and during angiotensin infusion in man. Arch Int Pharmacodyn Ther (1970) 0.75
Frusemide renography. Lancet (1967) 0.75
Application of a simple fluorometric method on absorption of canrenone. Int J Clin Pharmacol Biopharm (1976) 0.75
Decreased antidiuretic response to lysine-vasopressin after acute administration of glibenclamide in healthy subjects. Acta Diabetol Lat (1975) 0.75
Interference of psychotropic drugs with cortisol determinations. Horm Metab Res (1974) 0.75
Relationships between glucose-induced elevation of serum potassium in the upright posture, hormonal changes and renal functions in captopril-treated hypertensives. Horm Metab Res (1984) 0.75
Site of action of frusemide. Lancet (1968) 0.75
Renographic studies during furosemide diuresis in partial ureteral obstruction. Radiol Clin Biol (1969) 0.75
Inhibition of clofibrate-induced antidiuresis by glybenclamide in patients with pituitary diabetes insipidus. J Clin Pharmacol (1974) 0.75
Paradoxical increase in renal concentrating operation in response to furosemide during hypertonic saline infusion in man. Med Exp Int J Exp Med (1969) 0.75
A possible role for human growth hormone (HGH) in the protection from glucose-induced hyperkalemia in normaldosteronemic diabetes. Endokrinologie (1982) 0.75
Excessive decrease in free water clearance induced by furosemide and ethacrynic acid in nephrogenic diabetes insipidus associated with renal tubular acidosis. Endokrinologie (1973) 0.75